This promising cancer treatment could represent a $25 billion market opportunity
Skynesher | E+ | fake images Big Pharma is betting billions on a promising class of cancer treatments that some…
investment strategy
Stocks set to move as this corner of the cancer therapy market heats up
Much attention has been paid lately to a corner of the oncology market called radiopharmaceuticals. The therapy seeks to destroy…
Clients say they cannot access funds
Sarinyapinngam | Stock | fake images A dispute between a financial technology startup and its banking partners has potentially ensnared…
The stock market is again under attack by the Federal Reserve. Plus, the quiet return of Starbucks
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
Buy now, pay later businesses must comply with US credit card laws.
CFPB Director Rohit Chopra testifies during a House Financial Services Committee hearing on June 14, 2023. Tom Williams | Cq-roll…
Activist's willingness to buy Abbott rival and look beyond baby formula suits
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
Eli Lilly shares hit new highs after a regulatory victory in China. This is a big problem
Every weekday, the CNBC Investing Club with Jim Cramer hosts a “Morning Meeting” livestream at 10:20 a.m. ET. Here's a…
JPMorgan Stock Is Too Expensive
Jamie Dimon, CEO of JPMorgan Chase, testifies during the Senate Banking, Housing and Urban Affairs Committee hearing titled Annual Oversight…
JPMorgan CEO Jamie Dimon hints at retirement within five years
Jamie Dimon, CEO of JPMorgan Chase & Co., at the UK Global Investment Summit at Hampton Court Palace in London,…
Danaher shows how holding a good company's troubled stock can pay off
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…